Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1.

T A McCaffrey, Harry L. Bush(Los Alamos National Laboratory)

Journal of Clinical Investigation

December 1, 1995

10.1172/jci118333

Cited by 170

Related Papers

Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2-macroglobulin inactive complex.

|The Journal of Cell Biology|1989|221

Specific inhibition of eIF-5A and collagen hydroxylation by a single agent. Antiproliferative and fibrosuppressive effects on smooth muscle cells from human coronary arteries.

|Journal of Clinical Investigation|1995|58